Keyphrases
Mass Vaccination
100%
Celiac Disease Autoimmunity
100%
COVID-19 Vaccine
100%
BNT162b2 Vaccine
100%
Survival Analysis
28%
Vaccinated Patients
28%
IgA-tTG
28%
Clinical Trials
14%
Between-group
14%
Confidence Interval
14%
Retrospective Cohort Study
14%
Hazard Ratio
14%
Working Diagnosis
14%
Cox Regression
14%
Serology
14%
Celiac Disease
14%
Autoantibodies
14%
Kaplan-Meier
14%
Vaccine Effectiveness
14%
Vaccine Dose
14%
Log-rank Test
14%
COVID-19
14%
SARS-CoV-2 Infection
14%
Tissue Transglutaminase
14%
Immune Condition
14%
Breakthrough Infection
14%
COVID-19 Vaccination
14%
Breakthrough SARS-CoV-2 Infection
14%
Medicine and Dentistry
Coeliac Disease
100%
Autoimmunity
100%
Mass Immunization
100%
COVID-19 Vaccine
100%
Messenger RNA
100%
Infection
37%
Immunoglobulin A
25%
Survival Analysis
25%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Retrospective Cohort Study
12%
Hazard Ratio
12%
Proportional Hazards Model
12%
Clinical Trial
12%
Autoantibodies
12%
Protein Glutamine Gamma Glutamyltransferase
12%
Log Rank Test
12%
COVID-19
12%
COVID-19 Vaccination
12%
Pharmacology, Toxicology and Pharmaceutical Science
Coeliac Disease
100%
COVID-19 Vaccine
100%
Messenger RNA
100%
Infection
37%
Immunoglobulin A
25%
SARS Coronavirus
25%
Clinical Trial
12%
Cohort Study
12%
Autoantibodies
12%
Protein Glutamine Gamma Glutamyltransferase
12%